Abstract-The use of current antiepileptic drugs has been questioned due to their non selectivity and undesirable side effects. In pursuit of better anticonvulsant drug and the significance of semicarbazones as anticonvulsant pharmacophore, a series of novel benzimidazole substituted semicarbazones were designed, synthesized and evaluated for their anticonvulsant activity. Semicarbazones based benzimidazole analogues are hitherto unreported for their promising anticonvulsant activity. The synthesized molecules were characterized using elemental and spectral (IR, 1 H NMR, 13 C NMR and MS) analysis. The anticonvulsant activities of the compounds were investigated using maximal electroshock seizure (MES) model. The rotarod test was employed for neurotoxicity evaluation. Efforts were also made to establish structure-activity relationships among synthesized compounds. The results of these investigations confirmed that the pharmacophore model with four binding sites is vital for antiepileptic activity.
I. INTRODUCTION
Epilepsy is not a disease, but a syndrome of different cerebral disorders of central nervous system distinguished by the periodic sudden loss or impairment of consciousness, frequently followed by convulsions. About 50 million people worldwide have epilepsy, making this condition the second leading neurological disorder with almost 90% of these people being in developing countries. Epilepsy also affects about 4% of individuals over their lifetime [1] . Around 70 % of epileptic patients may be provided with adequate seizure controls with the help of conventional antiepileptic drugs such as phenobarbitone, phenytoin, carbamazepine, ethosuximide, valproate, benzodiazepine, but shows unfavorable adverse effects such as drowsiness, ataxia, gastrointestinal disturbances, hepatotoxicity, megaloblastic anaemia and sometimes even life threatening conditions [2] . Thus, there is a vast requirement for the development of more effective and safer anticonvulsant drugs.
In the recent years, aryl semicarbazones has been recognized as structurally novel class of compounds with remarkable antiepileptic activity [3] - [5] . The conformational studies of the existing anticonvulsant drugs such as phenytoin, carbamazepine, lamotrigine, rufinamide and phenobarbitone has led to the proposal of a model for anticonvulsant activity [6] (Fig. 1) . This semicarbazones based pharmacophore model comprises of the four essential binding sites as follows: (i) An aryl hydrophobic binding site (A) with halo substituent, preferably at para position; (ii) A hydrogen bonding domain (HBD); (iii) An electron donor group (D) and (iv) Another hydrophobic-hydrophilic site controlling the pharmacokinetic properties of the anticonvulsant (C) (Fig. 2) . In earlier pharmacophore model studies, our research group confirmed that the presence of aryl group (preferably halogen substituted) near the semicarbazone moiety is one of the important parameters for anticonvulsant activity [7] . The effect of adding benzimidazole nucleus to semicarbazone based pharmacophoric model for anticonvulsant activity has not been observed till now.
II. MATERIALS AND METHODS
All the chemicals and solvents used in this study were procured from E-Merck (Darmstadt, Germany), Aldrich (Steinheim, Germany) and Himedia (Mumbai, India). Melting points were determined by open capillary method and are uncorrected. Elemental analysis was performed using an elemental analyzer Heraeus Carlo Erba-1108, IR spectra were recorded on a Perkin Elmer IR spectrophotometer (KBr disc) (Perkin Elmer, Beaconsfield, UK), NMR spectra on a Bruker DRX-300 NMR spectrometer (DMSO-d 6 , TMS) (Bruker Bioscience, Billerica, MA, USA) and the electrospray mass spectra on a Micromass Quattro II triple-quadrupole mass spectrometer (Methanol) (Micromass, Manchester, UK).
The title compounds were prepared using the synthetic strategy described in scheme 1. The first step of synthetic route comprises of preparation of Imesatin (III) by reaction of isatin (I) with para-phenylenediamine (II) in the presence of ethanol. 1-(-4-(2-oxoindolin-3-ylideneamino)phenyl) urea (IV) was prepared from reaction of imesatin (III) with sodium cyanate in the presence of glacial acetic acid. The reaction of (IV) with hydrazine hydrate in the presence of ethanol resulted in the synthesis of 4(-4-{2-oxoindolin-3-ylideneamino}phenyl)semicarbazide (V). Title compounds [VI(a-j)] were prepared by reaction of the appropriate carbonyl compounds with (V) ( Table I) .
A. General Procedure for Synthesis of Imesatin (III)
The equimolar quantities (0.01 mol) of isatin and p-phenylenediamine were dissolved in sufficient quantity of methanol (30 ml) in the presence of acetic acid. The reaction mixture was refluxed for 1 h followed by standing at rt for 2 h resulted in the formation of crude imesatin. The product was recrystallized with ethanol [8] . 
B. General Procedure for Synthesis of 1-(-4-(2-oxoindolin-3-ylideneamino)phenyl) Urea (IV)
The appropriate imesatin (0.01 mol) was dissolved in 10-30 ml of glacial acetic acid diluted to 100 ml with distilled water. An equimolar quantity of sodium cyanate in 20-30 ml warm water was added with stirring. The reaction mixture was allowed to stand for several h followed on an ice bath, the precipitates obtained were collected by filtration, washed with cold water and were recrystallized from 90% aqueous ethanol.
C. General Procedure for Synthesis of 4(-4-{2-oxoindolin-3-ylideneamino}phenyl)semicarbazide (V)
The compound IV (0.01 mol) was dissolved in 30-40 ml of ethanol. To this was added an equimolar solution of hydrazine hydrate in 5 ml of water. The reaction mixture was made alkaline by adding 4 g of NaOH pellets. The contents were then refluxed for 2-8 h followed by cooling on an ice bath. The product obtained was filtered and recrystallized from 90% ethanol.
D. General Procedure for Synthesis of 1-(3-substitutedbenzylidene-4-(4-(2-oxoindoline-3ylidenea mino)phenyl)semicarazinde (VI)
The equimolar quantity (0.06 mol) of V and carbonyl compound were dissolved in 20 ml of ethanol (95%) and pH of reaction was adjusted between 4 and 5 using glacial acetic acid. The mixture was reflux for 30 min to 1 h and then cooled in an ice bath. The solution was poured on crushed ice to induce crystallization. The resulting precipitates were filtered, dried and recrystallized from aqueous ethanol (95%).
The structures of the compounds were confirmed on the basis of elemental analysis, IR, 1 H-NMR, 13 C-NMR and mass spectroscopy. The results of spectroscopic studies showed data in conformity to the structures of the respective compounds.
The anticonvulsant screening [3] , [4] , [9] was performed using male albino mice (swiss, 18-25 g). The anticonvulsant activity of the test compounds was evaluated by maximal electroshock seizure (MES) model. The MES test identifies those compounds which stop seizure spread and it is used to evaluate drug effectiveness in tonic-clonic (grand mal) type of epilepsy. Phenytoin was used as the standard drugs for the comparison. Acute neurological toxicity was determined in the rotorod test [3] , [4] , [9] . Procedures employed for evaluation of anticonvulsant activity and neurotoxicity were reviewed and approved by the University Animal Ethical Committee.
E. MES Test
The maximal seizure usually consists of a short period of tonic extension of the hind limbs and a final clonic episode. The maximal electroshock seizures were elicited with altering current of 60 mA intensity delivered for 0. 
F. Neurotoxicity Screening
Neurotoxicity (minimal motor impairment) was evaluated in mice by the rotorod test. The mice were trained to stopover an accelerating rotorod of diameter 3.2 cm that rotates at 6 revolutions per min. Only those animals which had proven their competence to remain on the revolving rod for at least 1 min were considered for the test. Previously trained mice were given test compounds i.p. in dose of 50 mg/kg. 30 min after i.p. administration the mice were placed on the rotating rod. Neurotoxicity was indicated by the failure of the animals to maintain equilibrium on the rod for at least 1 min in each of the three trials. accomplished all the pharmacophore structural requirements. In the present study, 1-(3-nitrobenzylidene-4-(4-(2-oxoindoline-3ylideneamino)p henyl)semicarazinde [VI(d)] came out as the most active compound, showing considerable activity in maximal electroshock seizure model with minimum neurotoxicity. The results attained showed that the most of the benzimidazole based semicarbazones showed anticonvulsant activity. Thus, the results validated that four pharmacophore elements in semicarbazones are crucial for their antiepileptic activity.
IV. CONCLUSION
A series of novel benzimidazole substituted semicarbazones containing 1,3,4-oxadiazole nucleus were synthesized to accomplish the structural prerequisite vital for antiepileptic activity. The structure activity relationship studies represent that anticonvulsant activity changes on differing p-substituted group on aryl moiety in the following manner: nitro > hydroxy > chloro > methoxy group. While anticonvulsant activity changes on varying the substitution attached to carbimino carbon atom as follows: CH 3 > H. Our results supported that the pharmacophore model with four structural features is imperative for anticonvulsant activity. These new data might be advantageous in the future design and development of semicarbazones as novel anticonvulsants.
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